Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy, Temporal Lobe | 17 | 2025 | 142 | 3.380 |
Why?
|
| Epilepsy | 14 | 2024 | 434 | 2.340 |
Why?
|
| Electroencephalography | 24 | 2025 | 798 | 2.100 |
Why?
|
| Electrocorticography | 7 | 2024 | 46 | 1.640 |
Why?
|
| Seizures | 13 | 2024 | 312 | 1.300 |
Why?
|
| Hippocampus | 11 | 2025 | 451 | 1.000 |
Why?
|
| Drug Resistant Epilepsy | 5 | 2024 | 58 | 0.940 |
Why?
|
| Subdural Space | 1 | 2024 | 17 | 0.830 |
Why?
|
| Epilepsy, Generalized | 3 | 2023 | 42 | 0.760 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 190 | 0.680 |
Why?
|
| Encephalitis | 2 | 2018 | 46 | 0.650 |
Why?
|
| Brain | 8 | 2024 | 2337 | 0.610 |
Why?
|
| Brain Waves | 1 | 2019 | 34 | 0.580 |
Why?
|
| Implantable Neurostimulators | 1 | 2018 | 12 | 0.560 |
Why?
|
| Limbic Encephalitis | 1 | 2018 | 11 | 0.540 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 34 | 0.540 |
Why?
|
| Laser Therapy | 4 | 2020 | 150 | 0.530 |
Why?
|
| Stereotaxic Techniques | 4 | 2024 | 81 | 0.520 |
Why?
|
| Scalp | 4 | 2022 | 69 | 0.510 |
Why?
|
| Theta Rhythm | 3 | 2025 | 38 | 0.500 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2016 | 9 | 0.490 |
Why?
|
| Antibodies | 1 | 2018 | 346 | 0.470 |
Why?
|
| Prone Position | 4 | 2017 | 61 | 0.460 |
Why?
|
| Auditory Cortex | 3 | 2022 | 66 | 0.440 |
Why?
|
| Sleep | 7 | 2022 | 448 | 0.390 |
Why?
|
| Death, Sudden | 4 | 2019 | 43 | 0.390 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2014 | 195 | 0.390 |
Why?
|
| Evoked Potentials | 1 | 2014 | 193 | 0.380 |
Why?
|
| Epilepsies, Partial | 2 | 2024 | 52 | 0.360 |
Why?
|
| Visual Cortex | 3 | 2022 | 244 | 0.360 |
Why?
|
| Humans | 46 | 2025 | 93132 | 0.350 |
Why?
|
| Auditory Perception | 4 | 2022 | 104 | 0.320 |
Why?
|
| Temporal Lobe | 4 | 2025 | 187 | 0.320 |
Why?
|
| Adult | 23 | 2025 | 27849 | 0.310 |
Why?
|
| Lennox Gastaut Syndrome | 2 | 2020 | 16 | 0.310 |
Why?
|
| Corpus Callosum | 2 | 2020 | 56 | 0.300 |
Why?
|
| Young Adult | 15 | 2025 | 6922 | 0.300 |
Why?
|
| Nerve Net | 2 | 2025 | 394 | 0.290 |
Why?
|
| Electrodes, Implanted | 2 | 2024 | 196 | 0.290 |
Why?
|
| Piriform Cortex | 2 | 2020 | 12 | 0.290 |
Why?
|
| Brain Mapping | 3 | 2024 | 565 | 0.280 |
Why?
|
| Middle Aged | 20 | 2025 | 27535 | 0.260 |
Why?
|
| Cerebral Cortex | 4 | 2020 | 569 | 0.250 |
Why?
|
| Electrodes | 2 | 2024 | 97 | 0.240 |
Why?
|
| Sclerosis | 2 | 2017 | 31 | 0.240 |
Why?
|
| Female | 23 | 2025 | 48542 | 0.230 |
Why?
|
| Male | 24 | 2025 | 44355 | 0.210 |
Why?
|
| Video Recording | 4 | 2020 | 210 | 0.200 |
Why?
|
| Retrospective Studies | 10 | 2023 | 10128 | 0.190 |
Why?
|
| Memory Consolidation | 1 | 2022 | 15 | 0.190 |
Why?
|
| Visual Perception | 3 | 2022 | 333 | 0.190 |
Why?
|
| Deep Brain Stimulation | 1 | 2023 | 89 | 0.180 |
Why?
|
| Thalamus | 1 | 2023 | 131 | 0.180 |
Why?
|
| Neurocysticercosis | 1 | 2021 | 6 | 0.170 |
Why?
|
| Speech Perception | 1 | 2021 | 73 | 0.170 |
Why?
|
| Wakefulness | 3 | 2020 | 128 | 0.160 |
Why?
|
| Anticipation, Psychological | 1 | 2020 | 10 | 0.160 |
Why?
|
| Olfactory Perception | 1 | 2020 | 23 | 0.160 |
Why?
|
| Sleep Apnea, Central | 1 | 2019 | 16 | 0.150 |
Why?
|
| Neuronavigation | 1 | 2019 | 24 | 0.150 |
Why?
|
| Acoustic Stimulation | 4 | 2022 | 129 | 0.150 |
Why?
|
| Language | 1 | 2020 | 160 | 0.140 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2019 | 39 | 0.140 |
Why?
|
| Evoked Potentials, Visual | 1 | 2019 | 90 | 0.140 |
Why?
|
| Carboxy-Lyases | 1 | 2018 | 18 | 0.140 |
Why?
|
| Adolescent | 9 | 2020 | 9550 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3450 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 67 | 0.130 |
Why?
|
| Amygdala | 2 | 2017 | 86 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1160 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2019 | 282 | 0.130 |
Why?
|
| Delta Rhythm | 1 | 2016 | 18 | 0.120 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 257 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2018 | 276 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2024 | 9070 | 0.120 |
Why?
|
| Personality | 1 | 2018 | 140 | 0.120 |
Why?
|
| Smell | 1 | 2017 | 120 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 541 | 0.120 |
Why?
|
| Occipital Lobe | 1 | 2015 | 24 | 0.120 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2016 | 111 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2021 | 4546 | 0.110 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2014 | 10 | 0.100 |
Why?
|
| Dominance, Cerebral | 1 | 2014 | 60 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 255 | 0.100 |
Why?
|
| Aged | 6 | 2021 | 20395 | 0.100 |
Why?
|
| Lasers | 2 | 2024 | 99 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2013 | 24 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 145 | 0.100 |
Why?
|
| Functional Laterality | 3 | 2019 | 204 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 347 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2012 | 112 | 0.090 |
Why?
|
| Oxygen | 1 | 2016 | 749 | 0.080 |
Why?
|
| Prognosis | 1 | 2016 | 3890 | 0.070 |
Why?
|
| Anticonvulsants | 2 | 2020 | 127 | 0.060 |
Why?
|
| Time Factors | 3 | 2019 | 5380 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2025 | 344 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2562 | 0.050 |
Why?
|
| Neocortex | 1 | 2025 | 98 | 0.050 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2023 | 10 | 0.050 |
Why?
|
| Risk Factors | 3 | 2020 | 5900 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2552 | 0.050 |
Why?
|
| Amplifiers, Electronic | 1 | 2022 | 6 | 0.050 |
Why?
|
| Spatial Memory | 1 | 2022 | 28 | 0.050 |
Why?
|
| Biomarkers | 2 | 2019 | 1905 | 0.050 |
Why?
|
| Sound | 1 | 2022 | 24 | 0.050 |
Why?
|
| Speech | 1 | 2021 | 90 | 0.040 |
Why?
|
| Mental Recall | 1 | 2022 | 172 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 753 | 0.040 |
Why?
|
| Action Potentials | 1 | 2024 | 578 | 0.040 |
Why?
|
| Atrophy | 1 | 2021 | 128 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2023 | 194 | 0.040 |
Why?
|
| Psychosurgery | 1 | 2020 | 15 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 459 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 913 | 0.040 |
Why?
|
| Calcinosis | 1 | 2021 | 219 | 0.040 |
Why?
|
| Biological Clocks | 1 | 2020 | 76 | 0.040 |
Why?
|
| Child | 2 | 2020 | 7273 | 0.040 |
Why?
|
| Pneumonia | 1 | 2020 | 192 | 0.040 |
Why?
|
| Neurophysiological Monitoring | 1 | 2018 | 17 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 350 | 0.030 |
Why?
|
| Polysomnography | 1 | 2018 | 152 | 0.030 |
Why?
|
| Electroencephalography Phase Synchronization | 1 | 2017 | 3 | 0.030 |
Why?
|
| Posture | 1 | 2017 | 121 | 0.030 |
Why?
|
| Gamma Rhythm | 1 | 2017 | 15 | 0.030 |
Why?
|
| Algorithms | 1 | 2025 | 1948 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 108 | 0.030 |
Why?
|
| Odorants | 1 | 2017 | 71 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2019 | 506 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1318 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7039 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 341 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 3814 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2705 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1697 | 0.020 |
Why?
|
| Heart Rate | 1 | 2013 | 505 | 0.020 |
Why?
|